← Back

Arecor Therapeutics PLC

AREC.LSEGBX
72.50-6.5%1Y · GBX

Arecor Therapeutics plc is a clinical-stage biotechnology company based in Little Chesterford, United Kingdom, founded in 2007. It develops therapeutics for diabetes, obesity, and other cardiometabolic diseases. Its lead product candidate, AT278, is a disruptor insulin designed to enhance Automated Insulin Delivery (AID) systems and improve care for people with diabetes. The company is also developing a novel oral delivery platform using a GLP-1 receptor agonist.

Price · split & dividend adjusted
News & notes moving AREC.LSE
United KingdomUnited StatesZambia
AREC.LSE▲

Blackbird Joins Google Chromebook Perks as Arecor Closes £5.13m Raise

Blackbird PLC has been selected for Google's Chromebook perks programme, giving its elevate.io editing platform a route to tens of millions of users, with a UK test launch due in October. Tertiary Minerals PLC is preparing to drill deeper at Mushima North in Zambia, testing whether its silver-copper discovery extends into a higher-grade sulphide deposit. Arecor Therapeutics PLC closed its equity raise at £5.13 million after an oversubscribed retail offer, with the cash funding work towards a US phase II trial for its ultra-rapid-acting insulins. Futura Medical PLC pushed back its sale deadline by around four weeks, citing strong interest, and is lining up an interim finance chief as its current FD steps down. Rainbow Rare Earths Ltd appointed TechMet's chief legal officer Ashleigh Woolf as a non-executive director, replacing Darryll Castle, who has resigned from the board.
AREC.LSE · Capital · Positive Arecor closed its equity raise at £5.13m, oversubscribed, funding its US phase II insulin trial.
BIRD.LSE · Demand · Positive Blackbird's elevate.io was selected for Google's Chromebook perks programme, giving it a route to tens of millions of users.
FUM.LSE · · Neutral Futura pushed back its sale deadline by ~4 weeks citing strong interest and is lining up an interim finance chief.
RBW.LSE · Regulation · Neutral Rainbow Rare Earths appointed a new non-executive director as Darryll Castle resigned from the board.
TYM.LSE · Technology · Neutral Tertiary Minerals is preparing to drill deeper at Mushima North to test if its silver-copper discovery extends into higher-grade sulphide.
Read original ↗
Proactive Investors·3dRead more →